International Conference on Inflammatory Bowel Disease and Therapy
(ICIBDT-26)

12th December 2026 || Visakhapatnam - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Inflammatory Bowel Disease and Therapy (ICIBDT), scheduled to be held on 12th December 2026 in Visakhapatnam, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Gastroenterology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Pathophysiology of Inflammatory Bowel Disease
    This session will explore the underlying mechanisms contributing to the development and progression of inflammatory bowel disease, including genetic, environmental, and immunological factors. Emphasis will be placed on recent discoveries that enhance our understanding of disease etiology. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Advancements in Crohn's Disease Management
    This track will focus on the latest therapeutic strategies and interventions for managing Crohn's disease, including pharmacological and non-pharmacological approaches. Participants will discuss the efficacy of novel treatments and their implications for patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Microbiome and Inflammatory Bowel Disease
    This session will delve into the role of the gut microbiome in inflammatory bowel disease, examining how microbial composition influences disease activity and treatment responses. Researchers will present findings on microbiome-targeted therapies and their potential benefits. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Nutritional Considerations in Inflammatory Bowel Disease
    This track will address the importance of nutrition in the management of inflammatory bowel disease, highlighting dietary interventions that can improve patient quality of life. Experts will discuss the impact of specific diets on disease flare-ups and remission. Aligned SDGs: SDG 2 – Zero Hunger  |  SDG 3 – Good Health and Well-being
  • Track 05 – Psychosocial Aspects of Living with Inflammatory Bowel Disease
    This session will explore the psychological and social challenges faced by patients with inflammatory bowel disease, including anxiety, depression, and stigma. Discussions will focus on the importance of mental health support and coping strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Innovations in Diagnostic Techniques
    This track will highlight recent advancements in diagnostic methodologies for inflammatory bowel disease, including imaging technologies and biomarker discovery. Participants will evaluate the impact of these innovations on early detection and disease monitoring. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Pediatric Perspectives on Inflammatory Bowel Disease
    This session will focus on the unique challenges and treatment considerations for inflammatory bowel disease in pediatric populations. Experts will discuss growth, development, and the long-term implications of early-onset disease. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Surgical Interventions in Inflammatory Bowel Disease
    This track will examine the role of surgical management in inflammatory bowel disease, including indications for surgery and postoperative outcomes. Surgeons will share insights on evolving techniques and patient selection criteria. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Biologics and Targeted Therapies in Crohn's Disease
    This session will provide an overview of biologic therapies and their mechanisms of action in the treatment of Crohn's disease. Participants will discuss the latest clinical trial results and their implications for practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Health Disparities in Inflammatory Bowel Disease
    This track will investigate the disparities in access to care and treatment outcomes among different populations affected by inflammatory bowel disease. Researchers will present data on socioeconomic factors and their impact on disease management. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Future Directions in Inflammatory Bowel Disease Research
    This session will highlight emerging research trends and future directions in the field of inflammatory bowel disease. Experts will discuss potential breakthroughs and the importance of interdisciplinary collaboration in advancing knowledge and treatment. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 2 SDG 2
    Zero Hunger
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228